{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:08:18Z","timestamp":1781932098295,"version":"3.54.5"},"update-to":[{"DOI":"10.1371\/journal.pntd.0013659","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000}}],"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Sporotrichosis is a subcutaneous mycosis caused by\n                      <jats:italic>\n                        <jats:italic>Sporothrix spp.<\/jats:italic>\n                      <\/jats:italic>\n                      , typically acquired through traumatic inoculation of fungal spores from soil, plants and infected cat scratches. The disease manifests in various clinical forms, including lymphocutaneous, ocular, bone, and disseminated infections. Standard treatment relies on prolonged administration of antifungals such as itraconazole, terbinafine, and potassium iodide, often requiring months for complete resolution. Moreover, treatment challenges include slow clinical response, recurrence, and potential drug toxicity. Hyperbaric oxygen therapy has been investigated as a potential adjuvant for invasive fungal infections due to its antimicrobial properties, enhanced tissue oxygenation, and immunomodulatory effects, which may contribute to improved healing and therapeutic outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with a confirmed diagnosis of cutaneous\/lymphocutaneous sporotrichosis were divided into two groups to receive either itraconazole or itraconazole plus hyperbaric oxygen therapy. The primary outcomes were time to cure and therapeutic response. The intervention group was assessed weekly through clinical parameters and photographic records, and the control group was assessed monthly.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients who received hyperbaric oxygen therapy experienced a much shorter healing time than those who did not. The average time until a cure was 208.53 days in the itraconazole group compared to 57.54 days in the itraconazole plus hyperbaric oxygen therapy group. Patients in the Hyperbaric oxygen therapy group received an average of 18.23 hyperbaric sessions and were 65 times more likely to achieve faster healing than those who did not. Notably, with each additional year of age, the chances of rapid healing decreased by 2%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings suggest that adjuvant hyperbaric oxygen therapy significantly accelerates the healing of fixed cutaneous\/lymphocutaneous sporotrichosis. The results also highlight hyperbaric oxygen therapy\u00b4s potential to enhance treatment efficacy and reduce the burden of prolonged antifungal therapy. These results support further investigation of this valuable adjunctive treatment in the management of sporotrichosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0013659","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:47:42Z","timestamp":1761760062000},"page":"e0013659","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adjuvant hyperbaric oxygen therapy reduces the duration of sporotrichosis treatment"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9345-018X","authenticated-orcid":true,"given":"Helena","family":"Duani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Soares","family":"Bifano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico Figueiredo","family":"Am\u00e2ncio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinfay Maximilian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian Mesquita","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Macieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00falio Pinho","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unai","family":"Tupinamb\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"issue":"1","key":"pntd.0013659.ref001","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s42770-021-00658-1","article-title":"The Historical Burden of Sporotrichosis in Brazil: a Systematic Review of Cases Reported from 1907 to 2020","volume":"53","author":"VBS Rabello","year":"2022","journal-title":"Braz J Microbiol"},{"issue":"11","key":"pntd.0013659.ref002","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.3390\/microorganisms10112152","article-title":"Sporotrichosis: A Review of a Neglected Disease in the Last 50 Years in Brazil","volume":"10","author":"CM Alvarez","year":"2022","journal-title":"Microorganisms"},{"key":"pntd.0013659.ref003","article-title":"Esporotricose humana passa a ser de notifica\u00e7\u00e3o compuls\u00f3ria.","volume-title":"Minist\u00e9rio da Sa\u00fade [Internet]"},{"issue":"6","key":"pntd.0013659.ref004","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1590\/S0074-02762001000600006","article-title":"Sporotrichosis: an emergent zoonosis in Rio de Janeiro","volume":"96","author":"MB de Lima Barros","year":"2001","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"4","key":"pntd.0013659.ref005","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1086\/381200","article-title":"Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases","volume":"38","author":"L Barros MB de","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"7","key":"pntd.0013659.ref006","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0000000000004333","article-title":"First Case of Sporotrichosis in a Child in a Nonendemic Region of Brazil","volume":"43","author":"LM Camandaroba","year":"2024","journal-title":"Pediatr Infect Dis J"},{"key":"pntd.0013659.ref007","author":"O-C Rosane","year":"2000"},{"key":"pntd.0013659.ref008","first-page":"9453701","article-title":"Lymphocutaneous Sporotrichosis Refractory to First-Line Treatment","volume":"2021","author":"Jr Belda W","year":"2021","journal-title":"Case Rep Dermatol Med"},{"key":"pntd.0013659.ref009","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.biopha.2018.10.142","article-title":"Hyperbaric oxygen therapy: Antimicrobial mechanisms and clinical application for infections","volume":"109","author":"MY Memar","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"pntd.0013659.ref010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1469-0691.2005.01170.x","article-title":"Hyperbaric oxygen as an adjunctive treatment for zygomycosis","volume":"11","author":"BV John","year":"2005","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"pntd.0013659.ref011","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/08850666241313136","article-title":"A Review of Emerging Evidence and Clinical Applications of Hyperbaric Oxygen Therapy","volume":"40","author":"SH Patel","year":"2025","journal-title":"J Intensive Care Med"},{"issue":"1","key":"pntd.0013659.ref012","article-title":"Narrative Review: Pyoderma Gangrenosum","volume":"16","author":"AN Park","year":"2024","journal-title":"Cureus"},{"issue":"3","key":"pntd.0013659.ref013","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00068-023-02426-2","article-title":"Adjunctive hyperbaric oxygen therapy in the management of severe lower limb soft tissue injuries: a systematic review","volume":"50","author":"E Kwee","year":"2024","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"12","key":"pntd.0013659.ref014","doi-asserted-by":"crossref","first-page":"950","DOI":"10.12968\/jowc.2022.0213","article-title":"Adjunctive hyperbaric oxygen therapy and negative pressure wound therapy for hard-to-heal wounds: a systematic review and meta-analysis","volume":"33","author":"L Yang","year":"2024","journal-title":"J Wound Care"},{"issue":"3","key":"pntd.0013659.ref015","doi-asserted-by":"crossref","first-page":"108973","DOI":"10.1016\/j.jdiacomp.2025.108973","article-title":"The role of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers - A literature review","volume":"39","author":"K Mackay","year":"2025","journal-title":"J Diabetes Complications"},{"issue":"2","key":"pntd.0013659.ref016","article-title":"Clinical Outcomes of Hyperbaric Oxygen Therapy for Diabetic Foot Ulcers: A Systematic Review","volume":"17","author":"U Damineni","year":"2025","journal-title":"Cureus"},{"issue":"9","key":"pntd.0013659.ref017","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/medicina57090864","article-title":"A General Overview on the Hyperbaric Oxygen Therapy: Applications, Mechanisms and Translational Opportunities","volume":"57","author":"MA Ortega","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"pntd.0013659.ref018","doi-asserted-by":"crossref","first-page":"24","DOI":"10.28920\/dhm47.1.24-32","article-title":"Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment","volume":"47","author":"D Mathieu","year":"2017","journal-title":"Diving Hyperb Med"},{"issue":"3","key":"pntd.0013659.ref019","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01953-17","article-title":"Hyperbaric Oxygen Reduces Aspergillus fumigatus Proliferation In Vitro and Influences In Vivo Disease Outcomes","volume":"62","author":"S Dhingra","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"pntd.0013659.ref020","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1586\/eri.09.76","article-title":"Hyperbaric oxygen therapy as an anti-infective agent","volume":"7","author":"M Cim\u015fit","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"pntd.0013659.ref021","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s42770-020-00307-z","article-title":"Antifungal resistance on Sporothrix species: an overview","volume":"52","author":"SB Waller","year":"2021","journal-title":"Braz J Microbiol"},{"issue":"5","key":"pntd.0013659.ref022","first-page":"355","article-title":"Hyperbaric oxygen in the treatment of invasive fungal infections: a single-center experience","volume":"9","author":"E Segal","year":"2007","journal-title":"Isr Med Assoc J"},{"key":"pntd.0013659.ref023"},{"issue":"2","key":"pntd.0013659.ref024","doi-asserted-by":"crossref","first-page":"145","DOI":"10.22462\/704","article-title":"Controlled CMS Data Demonstrates a Cost and Clinical Advantage for Hyperbaric Oxygen for Radiation Cystitis","volume":"51","author":"JJ Feldmeier","year":"2024","journal-title":"Undersea Hyperb Med"},{"issue":"2","key":"pntd.0013659.ref025","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1017\/S0266462308080252","article-title":"Cost-effectiveness and budget impact of adjunctive hyperbaric oxygen therapy for diabetic foot ulcers","volume":"24","author":"AW Chuck","year":"2008","journal-title":"Int J Technol Assess Health Care"},{"issue":"3","key":"pntd.0013659.ref026","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1468-3083.2010.03785.x","article-title":"Efficacy and safety of itraconazole pulses vs. continuous regimen in cutaneous sporotrichosis","volume":"25","author":"Y Song","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"pntd.0013659.ref027","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s11046-020-00425-0","article-title":"The threat of emerging and re-emerging pathogenic Sporothrix species","volume":"185","author":"AM Rodrigues","year":"2020","journal-title":"Mycopathologia"},{"issue":"5","key":"pntd.0013659.ref028","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1590\/0074-02760160527","article-title":"Minimal inhibitory concentration distributions and epidemiological cutoff values of five antifungal agents against Sporothrix brasiliensis","volume":"112","author":"R Almeida-Paes","year":"2017","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"pntd.0013659.ref029","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mmcr.2019.10.005","article-title":"Meningeal and multiorgan disseminated sporotrichosis: A case report and autopsy study","volume":"26","author":"H Duani","year":"2019","journal-title":"Med Mycol Case Rep"},{"issue":"9","key":"pntd.0013659.ref030","doi-asserted-by":"crossref","DOI":"10.1111\/myc.13792","article-title":"The Emergence of New Sporothrix brasiliensis Genotypes in Current Epidemic of Sporotrichosis in Southeastern Brazil","volume":"67","author":"SA Colombo","year":"2024","journal-title":"Mycoses"},{"key":"pntd.0013659.ref031","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.addr.2018.04.008","article-title":"Drug delivery systems and materials for wound healing applications","volume":"127","author":"S Saghazadeh","year":"2018","journal-title":"Adv Drug Deliv Rev"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0013659","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013659","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:54:15Z","timestamp":1763751255000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013659"}},"subtitle":[],"editor":[{"given":"Luis R","family":"Martinez,","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0013659","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]}}}